DK1299095T3 - Klart vandigt anæstetisk præparat - Google Patents

Klart vandigt anæstetisk præparat

Info

Publication number
DK1299095T3
DK1299095T3 DK00991825T DK00991825T DK1299095T3 DK 1299095 T3 DK1299095 T3 DK 1299095T3 DK 00991825 T DK00991825 T DK 00991825T DK 00991825 T DK00991825 T DK 00991825T DK 1299095 T3 DK1299095 T3 DK 1299095T3
Authority
DK
Denmark
Prior art keywords
clear aqueous
anesthetic preparation
aqueous anesthetic
preparation
clear
Prior art date
Application number
DK00991825T
Other languages
Danish (da)
English (en)
Inventor
Shilpa Kocharekar
Srikanth Pai
Sangeeta Rivankar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Application granted granted Critical
Publication of DK1299095T3 publication Critical patent/DK1299095T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00991825T 2000-06-21 2000-12-14 Klart vandigt anæstetisk præparat DK1299095T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (2) 2000-06-21 2000-06-21

Publications (1)

Publication Number Publication Date
DK1299095T3 true DK1299095T3 (da) 2004-10-11

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00991825T DK1299095T3 (da) 2000-06-21 2000-12-14 Klart vandigt anæstetisk præparat

Country Status (26)

Country Link
US (1) US7138387B2 (2)
EP (1) EP1299095B1 (2)
JP (1) JP4907833B2 (2)
KR (1) KR100810066B1 (2)
CN (1) CN1254237C (2)
AP (1) AP2002002674A0 (2)
AT (1) ATE267592T1 (2)
AU (2) AU3597201A (2)
BG (1) BG107463A (2)
BR (1) BR0017268A (2)
CA (1) CA2414064C (2)
DE (1) DE60011149T2 (2)
DK (1) DK1299095T3 (2)
EA (1) EA005589B1 (2)
ES (1) ES2222271T3 (2)
HU (1) HUP0301646A3 (2)
IL (1) IL153387A0 (2)
IN (1) IN187686B (2)
MX (1) MXPA02012611A (2)
NO (1) NO20025999D0 (2)
NZ (1) NZ523643A (2)
PL (1) PL359624A1 (2)
PT (1) PT1299095E (2)
WO (1) WO2001097796A1 (2)
YU (1) YU2703A (2)
ZA (1) ZA200300336B (2)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (2) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
PL205271B1 (pl) * 2001-12-28 2010-03-31 Mgi Gp Kompozycja farmaceutyczna rozpuszczalnego w wodzie proleku propofolu
BR0307518A (pt) * 2002-02-01 2004-12-28 Shimoda Biotech Pty Ltd Composição farmacêutica
CN100438861C (zh) 2002-07-29 2008-12-03 变换药品公司 含水2,6-二异丙基苯酚药物组合物
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
CN103405405A (zh) * 2002-12-09 2013-11-27 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
JPWO2005067905A1 (ja) * 2004-01-14 2007-12-27 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
AU2005283726A1 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
CN101287447B (zh) * 2005-08-12 2012-10-24 印度血清及疫苗有限公司 包含丙泊酚的水性麻醉剂组合物
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
EP2257605A4 (en) * 2008-03-11 2011-03-09 3M Innovative Properties Co HART COATING COMPOSITION
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
CN102597116B (zh) 2009-07-21 2013-12-11 3M创新有限公司 可固化组合物、涂覆底片的方法、以及被涂覆的底片
EP2478033A1 (en) 2009-09-16 2012-07-25 3M Innovative Properties Company Fluorinated coating and phototools made therewith
US9051423B2 (en) 2009-09-16 2015-06-09 3M Innovative Properties Company Fluorinated coating and phototools made therewith
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
DK2484350T3 (en) * 2011-02-04 2016-08-01 Norbert Univ -Prof Dr Med Roewer A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
ES2784629T3 (es) 2011-11-29 2020-09-29 Jurox Pty Ltd Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
MX2015002252A (es) 2012-08-21 2015-07-21 Sage Therapeutics Inc Metodos para tratar epilepsia o estado de epilepsia.
EP3407875A4 (en) * 2016-01-29 2019-09-04 Cuda Anesthetics, LLC AQUEOUS PHARMACEUTICAL FORMULATION WITH PROPOFOL
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
MXPA02012611A (es) 2004-07-30
DE60011149T2 (de) 2005-07-07
YU2703A (sh) 2006-03-03
AP2002002674A0 (en) 2002-12-31
CN1254237C (zh) 2006-05-03
KR20030023875A (ko) 2003-03-20
AU3597201A (en) 2002-01-02
JP2003535893A (ja) 2003-12-02
WO2001097796A1 (en) 2001-12-27
IN187686B (2) 2002-06-08
KR100810066B1 (ko) 2008-03-05
US7138387B2 (en) 2006-11-21
PL359624A1 (en) 2004-08-23
HUP0301646A2 (hu) 2003-09-29
JP4907833B2 (ja) 2012-04-04
US20040014718A1 (en) 2004-01-22
NZ523643A (en) 2004-05-28
EP1299095A1 (en) 2003-04-09
EA200300047A1 (ru) 2003-06-26
BR0017268A (pt) 2003-05-27
EP1299095B1 (en) 2004-05-26
CA2414064A1 (en) 2001-12-27
ES2222271T3 (es) 2005-02-01
PT1299095E (pt) 2004-10-29
NO20025999L (no) 2002-12-13
ATE267592T1 (de) 2004-06-15
NO20025999D0 (no) 2002-12-13
IL153387A0 (en) 2003-07-06
HUP0301646A3 (en) 2005-06-28
EA005589B1 (ru) 2005-04-28
AU2001235972B2 (en) 2005-07-21
BG107463A (en) 2003-11-28
CA2414064C (en) 2013-01-08
ZA200300336B (en) 2004-04-08
DE60011149D1 (de) 2004-07-01
CN1454085A (zh) 2003-11-05

Similar Documents

Publication Publication Date Title
DK1299095T3 (da) Klart vandigt anæstetisk præparat
DK1857105T3 (da) Kathartisk præparat
NO20031483D0 (no) Vaksine
PL363005A1 (pl) Szczepionki
NL1017075A1 (nl) Preparaat.
NO20024172D0 (no) Vaksine
DE50104135D1 (de) Wässrige zusammensetzungen
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DE60124662D1 (de) Karosseriestruktur
DZ3409A1 (fr) Association therapeuthique
DK1199054T3 (da) Væskefrakturhånddel
NO20026175L (no) Vaksinesammensetning
DE60133295D1 (de) Sulphoniumsalz-verbindung
PL364773A1 (pl) Inhalator dozujący ksynafonian salmeterolu
NO20023367L (no) Glyburide-preparat
FI20002644A0 (fi) Liitäntäalusta
EE05197B1 (et) Linesoliid - kristallivorm II
DE60116202D1 (de) Perkutan absorbierende Zubereitung
DE60103683D1 (de) Wässrige Pestizidzusammensetzung
ATE450652T1 (de) Wässrige zusammensetzung
DK1389116T3 (da) Kathartisk præparat
BR0113783B1 (pt) Composição aquosa
NO20032957L (no) Farmasöytisk emulsjonspreparat
WO2002020075A3 (en) Nebulizer
FR2817889B1 (fr) Coffrage